Correlation between Gleason Scores of Prostatic Biopsies and Radical Prostatectomy Specimens
Keywords:
Prostate adenocarcinoma, Gleason grading, Gleason score, radical prostatectomy, TRUS core biopsyAbstract
Objective: The incidence of prostatic adenocarcinoma in Thailand has been increasing since 1989. Increased public
awareness may have contributed to early detection of the disease. Findings of abnormal digital examination, elevated serum
prostate-specific antigen (PSA) level and abnormal transrectal ultrasonography (TRUS) lead to more multiple core biopsies.
The Gleason grading system is the most common histologic grading of prostate carcinoma as approved by the World Health
Organization. The Gleason score, one of the prognostic predictors, thus plays an important part in the therapeutic decision.
The correlation between Gleason scores in biopsies and subsequent prostatectomy specimens is the main purpose of this
study. Associations of Gleason scores with organ confinement, perineural invasion and serum PSA levels before prostatectomy
were also studied.
Methods: The specimens from 100 patients, who underwent TRUS core biopsy and subsequent prostatectomy between
January 2001 and June 2004, were included.
Results: Gleason grade concordance was found in 35 cases. In TRUS core biopsy, 35, 9, and 1 cases were 1, 2, and 3
scores undergraded, respectively. Thirteen and 7 cases were 1 and 2 scores overgraded, respectively. Eighty three percent
show a difference of not more than 1 score.
Conclusion: We concluded that the Gleason scoring in prostatic biopsy remains a good predictor of the final Gleason
grading of the radical prostatectomy specimen. However, the urologists and radiotherapists should keep in mind that
undergrading and overgrading in TRUS core biopsies are both possible
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following conditions:
Copyright Transfer
In submitting a manuscript, the authors acknowledge that the work will become the copyrighted property of Siriraj Medical Journal upon publication.
License
Articles are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). This license allows for the sharing of the work for non-commercial purposes with proper attribution to the authors and the journal. However, it does not permit modifications or the creation of derivative works.
Sharing and Access
Authors are encouraged to share their article on their personal or institutional websites and through other non-commercial platforms. Doing so can increase readership and citations.